These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 30157919
21. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients]. Kılınçkaya Doğan H, Mutlu E, Köksoy S, Yılmaz VT, Koçak H, Çolak D, Mutlu D, Günseren F, Dinçkan A, Aliosmanoğlu İ, Süleymanlar G, Gültekin M. Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495 [Abstract] [Full Text] [Related]
22. Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Morishita M, Sada KE, Matsumoto Y, Hayashi K, Asano Y, Hiramatsu Asano S, Ohashi K, Miyawaki Y, Katsuyama E, Watanabe H, Kawabata T, Wada J. PLoS One; 2019 Apr; 14(7):e0218705. PubMed ID: 31291263 [Abstract] [Full Text] [Related]
24. CMV Infection Is Directly Related to the Inflammatory Status in Chronic Heart Failure Patients. García-Torre A, Bueno-García E, López-Martínez R, Rioseras B, Díaz-Molina B, Lambert JL, Quirós C, Alonso-Álvarez S, Alonso-Arias R, Moro-García MA. Front Immunol; 2021 Apr; 12():687582. PubMed ID: 34456907 [Abstract] [Full Text] [Related]
25. Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity. Tovar-Salazar A, Weinberg A. PLoS One; 2017 Apr; 12(7):e0180691. PubMed ID: 28683106 [Abstract] [Full Text] [Related]
26. A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology. Terrazzini N, Bajwa M, Vita S, Cheek E, Thomas D, Seddiki N, Smith H, Kern F. J Infect Dis; 2014 May 01; 209(9):1382-92. PubMed ID: 24203779 [Abstract] [Full Text] [Related]
28. Expanded peripheral CD4+CD28null T cells and its association with atherosclerotic changes in patients with end stage renal disease on hemodialysis. Okba AM, Abd El Raouf Raafat M, Nazmy Farres M, Abd El Nour Melek N, Amin MM, Gendy NN. Hum Immunol; 2019 Sep 01; 80(9):748-754. PubMed ID: 30853362 [Abstract] [Full Text] [Related]
29. CMV induces expansion of highly polyfunctional CD4+ T cell subset coexpressing CD57 and CD154. Pera A, Vasudev A, Tan C, Kared H, Solana R, Larbi A. J Leukoc Biol; 2017 Feb 01; 101(2):555-566. PubMed ID: 27566833 [Abstract] [Full Text] [Related]
30. Characterization of senescence biomarkers in rheumatoid arthritis: relevance to disease progression. Petersen LE, Schuch JB, de Azeredo LA, Baptista TSA, Motta JG, do Prado AD, Bauer ME. Clin Rheumatol; 2019 Oct 01; 38(10):2909-2915. PubMed ID: 31187337 [Abstract] [Full Text] [Related]
32. Cytomegalovirus infection modulates the phenotype and functional profile of the T-cell immune response to mycobacterial antigens in older life. Terrazzini N, Bajwa M, Vita S, Thomas D, Smith H, Vescovini R, Sansoni P, Kern F. Exp Gerontol; 2014 Jun 01; 54(100):94-100. PubMed ID: 24370373 [Abstract] [Full Text] [Related]
34. A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis. Sacre K, Hunt PW, Hsue PY, Maidji E, Martin JN, Deeks SG, Autran B, McCune JM. AIDS; 2012 Apr 24; 26(7):805-14. PubMed ID: 22313962 [Abstract] [Full Text] [Related]
35. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. Hooper M, Kallas EG, Coffin D, Campbell D, Evans TG, Looney RJ. J Rheumatol; 1999 Jul 24; 26(7):1452-7. PubMed ID: 10405929 [Abstract] [Full Text] [Related]
36. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells. Waldman WJ, Knight DA, Adams PW, Orosz CG, Sedmak DD. Transplantation; 1993 Dec 24; 56(6):1504-12. PubMed ID: 7904091 [Abstract] [Full Text] [Related]
37. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D. J Infect Dis; 2005 Mar 15; 191(6):873-80. PubMed ID: 15717261 [Abstract] [Full Text] [Related]
38. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. Fasth AE, Dastmalchi M, Rahbar A, Salomonsson S, Pandya JM, Lindroos E, Nennesmo I, Malmberg KJ, Söderberg-Nauclér C, Trollmo C, Lundberg IE, Malmström V. J Immunol; 2009 Oct 01; 183(7):4792-9. PubMed ID: 19752224 [Abstract] [Full Text] [Related]
39. PD-1 analysis on CD28(-) CD27(-) CD4 T cells allows stimulation-independent assessment of CMV viremic episodes in transplant recipients. Dirks J, Tas H, Schmidt T, Kirsch S, Gärtner BC, Sester U, Sester M. Am J Transplant; 2013 Dec 01; 13(12):3132-41. PubMed ID: 24148296 [Abstract] [Full Text] [Related]
40. CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD. Betjes MG, Weimar W, Litjens NH. J Am Soc Nephrol; 2009 Dec 01; 20(12):2661-6. PubMed ID: 19820127 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]